ABSTRACT: Intervertebral disc (IVD) degeneration is the leading trigger of low back pain, which causes disability and leads to enormous healthcare toll worldwide. Biological treatment with growth factors has evolved as potential therapy for IVD regeneration. Bone morphogenetic protein 2 (BMP-2) and BMP-7 have shown promise in this regard. In the current study, we evaluated the effect of BMP-2/7 heterodimer for disc regeneration both in vitro and in organ culture. Nucleus pulposus (NP) cells isolated from bovine caudal disc were cultured in a fibrin-hyaluronan (FBG-HA) hydrogel for up to 14 days. BMP-2/7 heterodimer covalently incorporated within the hydrogel up-regulated the aggrecan and type II collagen gene expression, and glycosaminoglycan synthesis of NP cells. The activity of the BMP-2/7 heterodimer was dose dependent. The higher dose of BMP-2/7 was further assessed in an IVD whole organ system. After 14 days of culture with cyclic dynamic load, the BMP-2/7 heterodimer delivered into the nucleotomized region showed potential to stimulate the gene expression and synthesis of proteoglycan in the remaining NP tissue after partial nucleotomy. The gene expression level of type I collagen and alkaline phosphatase in the native disc tissue were not affected by BMP-2/7 treatment, indicating no adverse fibroblastic or osteogenic effect on the disc tissue. Intradiscal delivery of BMP-2/7 heterodimer may be a promising therapeutic approach for NP regeneration. The current IVD whole organ partial nucleotomy model may be utilized for screening of other biomaterials or drugs to treat early degenerative disc disorders. Keywords: BMP-2/7 heterodimer; nucleus pulposus regeneration; intervertebral disc; whole organ culture
The intervertebral disc (IVD) is composed of the central gel-like nucleus pulposus (NP), the surrounding annulus fibrosus (AF), and the cartilaginous endplates that anchor the discs to the adjacent vertebrae. 1 The main functions of the IVD are to provide flexibility to the spine, and to transmit mechanical loads. Low back pain caused by IVD degeneration is the leading cause of disability worldwide. 2 Biological approaches for treatment of IVD degeneration have recently evolved, including the use of recombinant or natural proteins that can lead to the restoration of the disc. 3, 4 Bone morphogenetic proteins (BMPs) are involved in a variety of developmental processes, including bone, cartilage and IVD formation. 5, 6 In particular, BMP-2 and BMP-7 have been investigated in musculoskeletal research and have demonstrated promising potential for IVD regeneration. BMP-2 can up-regulate the gene expression and protein synthesis of extracellular matrix components in rabbit 7 and human NP cells 8, 9 cultured in vitro. In a rabbit in vivo study, treatment with adeno-associated viral vector carrying the gene for BMP-2 delayed the degeneration process in annulotomized discs. 10 BMP-7 was found to stimulate matrix synthesis in NP and AF cells from rabbit 11, 12 and human 13 origin. It also inhibited cellular apoptosis, induced by tumor necrosis factor-alpha, in human NP cells. 14 The effect of BMP-7 for IVD regeneration has furthermore been explored in various animal models, including rat, 15, 16 rabbit [17] [18] [19] and canine. 20 These studies revealed that intradiscal delivery of BMP-7 could restore disc height, stimulate extracellular matrix formation, and prevent degeneration.
Several studies have demonstrated that heterodimeric BMP-2/7 had a stronger activity for bone regeneration compared with BMP-2 or BMP-7 homodimers. 21, 22 Thus in this study, we investigated the effect of heterodimeric BMP-2/7 on the regeneration of the NP. In addition, the BMP-2/7 heterodimer was covalently incorporated within a fibrin-hyaluronan (FBG-HA) conjugate hydrogel 23 in order to obtain a slow release and prevent ectopic leakage. The dose dependent effects of the BMP-2/7 on the proliferation and matrix synthesis of bovine NP cells were first tested in vitro in a FBG-HA hydrogel. Then the effect of the BMP-2/7, covalently bound to the FBG-HA hydrogel, on IVD regeneration was evaluated ex vivo in a bovine IVD whole organ nucleotomy model. chromatography. TG-BMP-2 and BMP-7 monomers were then refolded in a buffer with CHAPS (3((3-cholamidopropyl)-dimethylammonio)-propansulfonate) and glutathione. In a final purification step, BMP-2/7 heterodimers were separated from unfolded monomers and homodimers using chromatography.
Fabrication of FBG-HA Conjugate Hydrogel
A FBG-HA conjugate hydrogel, which had been shown to promote NP cell growth and matrix production, 24 was used for BMP-2/7 delivery. Fibrinogen-HA conjugate solution was synthesized with 235 KDa HA at FBG/HA w/w ratio of 17:1 via a two-step procedure as described. 24 FBG-HA hydrogels were prepared by mixing 2/3 volume of FBG-HA conjugate with 1/3 volume of thrombin (5.2 U/ml) and allowed to polymerize at 37˚C for 20 min.
Effect of BMP-2/7 Heterodimer on NP Cells In Vitro Experimental Set-Up An in vitro cell culture experiment was performed to determine the potential of BMP-2/7 at different doses for promoting the activity of NP cells. NP cells were isolated from 4 to 10 months old bovine caudal discs. 24 Freshly isolated primary NP cells (passage 0) were encapsulated within FBG-HA conjugate hydrogel beads at a density of 1.2 Â 10 5 cells per bead (4 Â 10 6 cells/ml). Each bead (30 ml) was prepared by mixing 20 ml of FBG-HA, containing NP cells, with 10 ml of thrombin containing different concentrations of BMP-2/7. The final concentrations of BMP-2/7 in the FBG-HA hydrogels were 0 (hydrogel control), 1,000 ng/ml, and 5,000 ng/ml. Cell-gel constructs were cultured in Dulbecco's Modified Eagle Medium (DMEM, with 4.5 g/L glucose) with 2% fetal calf serum (FCS), 100 U/ml penicillin and 100 mg/ml streptomycin (1% Pen/Step) (all from Gibco, Praisley, UK), 1% ITSþ Premix (Discovery Labware, Inc., Bedford) and 50 mg/ml ascorbate-2-phosphate (SigmaAldrich, St. Louis, MO) for 7 or 14 days. The culture medium was changed 3Â per week.
Gene Expression Analysis
Total RNA was extracted from NP cells using TRI Reagent (Molecular Research Center, Cincinnati, OH) after 7 and 14 days of culture. Reverse transcription was carried out with TaqMan TM reagents (Applied Biosystems, Carlsbad, CA) using random hexamer primers and 0.5 mg of total RNA. Real-time PCR was performed using the Step-One-Plus instrument (Applied Biosystems). Table 1 shows the sequences of primers and TaqMan probes (Microsynth, Balgach, Switzerland) for collagen type I (COL1A2), collagen type II (COL2A1), and aggrecan (ACAN). For 18 S ribosomal RNA as endogenous control, a gene expression assay from Applied Biosystems was used (18S, 4310893E). The comparative Ct method was performed for relative quantification of target mRNA.
Glycosaminoglycan (GAG), DNA, and Collagen Content On days 7 and 14, the constructs were digested with 0.5 mg/ml proteinase K at 56˚C overnight. The GAG content in the hydrogels was measured using the 1,9-dimethylmethylene blue dye (DMMB) method 25 and was normalized to the DNA content in respective samples. GAG content in hydrogels on day 0 were subtracted from all samples. The DNA content in the hydrogels was measured with PicoGreen (Invitrogen, Eugene, OR) according to the manufacturer's instruction. The collagen content in the hydrogels was measured using a quantitative Hydroxy-Proline assay. 26 Effect of BMP-2/7 Heterodimer on IVDs With NP Replacement Under Dynamic Loading Ex Vivo Dissection of Bovine Caudal IVDs For assessment of BMP-2/7 in an IVD organ culture system, bovine caudal spines (4-10 months) were obtained from local abattoirs and dissected aseptically. IVDs including the cartilaginous endplates were harvested with a band saw (model 30/833, Exakt Apparatebau, Norderstedt, Germany) and cleaned with a Pulsavac jet-lavage system (Zimmer, Warsaw, IN). 24 Disc height and diameter were measured with a caliper before discs were washed with PBS containing 1,000 U/ml penicillin and 1,000 mg/ml streptomycin for 15 min. Then discs were transferred to a 6-well-plate containing disc culture medium (DMEM 4.5 g/L glucose, 2% FCS, 1% Pen/Strep, 1% ITSþ Premix, 50 mg/ml ascorbate-2-phosphate and 0.1% Primocin) and incubated overnight at 37˚C, 85% humidity, 5% CO 2 . After dissection, disc height of all IVDs ranged from 7 to 14 mm and disc diameter ranged from 13 to 20 mm.
Partial Nucleotomy and NP Replacement in Organ Cultured IVDs A partial nucleotomy was performed mechanically. 24 To reach a nucleotomy ratio of approximately 50% of the total NP volume for different sizes of discs, a NP cavity with diameter of 4 mm was created in small discs with diameter of 13-16.5 mm; in discs with diameter of 16.5-20 mm, a NP cavity with diameter of 6 mm was created. Discs were nucleotomized through the endplate by central incisions using a 4 or 6 mm biopsy punch and a number 11 blade. After removing an endplate core, the NP tissue below the endplate core was excised. Then 50-80 ml of FBG-HA hydrogel containing 0 or 5,000 ng/ml BMP-2/7 were pipetted into the nucleotomized region. Our previous study had shown that the FBG-HA hydrogel alone was not sufficient to restore the axial stiffness of partially nucleotomized discs under dynamic load. 24 Therefore, a polyurethane (PU) scaffold with swelling capability in situ 27 was subsequently placed into the FBG-HA hydrogel in the NP cavity. The PU scaffold was composed of a water absorbable core and an electrospun envelope. It has been used as a NP replacement material in this IVD organ culture nucleotomy model, thereby filling the nucleotomized region and restoring the mechanical property of nucleotomized IVDs. 27 Our previous study had revealed that dry PU scaffolds with 6 or 9 mm diameter obtained a diameter of 4 or 6 mm after hydration. 27 Therefore, dry PU scaffolds with 6 or 9 mm diameter were implanted into the NP defects with 4 or 6 mm diameter, respectively. After implantation of the biomaterials, the removed endplate stopper was re-inserted, and the crack between the stopper and the remaining endplate was sealed by polymethyl methacrylate (Vertecem Mixing Kit, Synthes, Teknimed S.A., Bigorre, France) according to manufacturer's instruction.
Dynamic Load on IVDs Within Bioreactor
To mimic physiologically relevant conditions in organ cultures, dynamic loading was applied on the IVDs with a bioreactor system. 28 IVDs were placed in custom made chambers filled with disc culture medium (see 4.1), and loaded dynamically for 3 h/day at 0-0.1 MPa and 0.1 Hz. Between dynamic loading cycles IVDs were cultured in 6-well plates to allow disc height recovery after dynamic loading, which mimics the physiological diurnal disc height change profile of human lumbar IVDs. 29 Medium was changed twice per day: 5 ml were added before loading, and 7 ml were added after loading. The repetitive dynamic 52 LI ET AL.
loading and free swelling culture was applied for 14 consecutive days. The experiments were performed using IVDs from 12 bovine tails, with two discs per tail randomly assigned to one of the two experimental groups: FBG-HA without BMP-2/7, or FBG-HA with 5,000 ng/ml BMP2/7.
Disc Height Change
Disc height was measured with a caliper at different time points: day 0 after dissection, day 1 after 1st load, day 2 after 1st recovery, day 7 after 7th load, day 8 after 7th recovery, day 14 after 14th load, and day 15 after 14th recovery. Each disc was measured at four positions and the mean value was used to calculate the percentage of disc height change. Disc height change was normalized to the initial dimension after dissection.
Biological Evaluations
After 14 days of culture with repetitive dynamic loading and free swelling recovery, endplates were removed, and remaining NP and AF tissues were harvested by using a biopsy punch and scalpel, respectively. Approximately 100 mg of each AF and NP was used for mRNA extraction; 50 mg was digested with 0.5 mg/ml proteinase K at 56˚C overnight for GAG, collagen and DNA assessment; 30 mg of NP was used for [ 35 S] sulfate incorporation assay to assess proteoglycan synthesis rate.
Gene Expression Analysis. Tissue samples were flash frozen, pulverized in liquid N 2 , and homogenized using a TissueLyser (Qiagen, Venlo, The Netherlands). Total RNA was extracted with TRI Reagent and reverse transcription was performed with SuperScript VILO cDNA Synthesis Kit (Life Technologies, Carlsbad, CA), which shows enhanced transcription efficiency for samples from IVD tissues with low RNA amounts. Real-time PCR was performed using the Step-One-Plus instrument (Applied Biosystems). The sequences of primers and TaqMan probes are shown in Table 1 . For 18 S ribosomal RNA, Versican (Bt03217632_m1), Biglycan (BGN, Bt 03244532_m1) and Alkaline Phosphatase (ALPL, Bt03244508_m1), gene expression assays from Applied Biosystems were used. The comparative Ct method was performed for relative quantification of target mRNA.
GAG, Collagen, and DNA Content. The GAG content in the NP and AF tissue was determined by using the DMMB method as mentioned above. The total amounts of collagen in NP and AF samples were measured using a quantitative Hydroxy-Proline assay. 26 DNA content was measured spectrofluorometrically using Hoechst (33258) dye. 35 S Sulfate Incorporation Rate. NP tissue was incubated for 16-20 h in disc culture medium supplemented with 2.5 mCi 35 S-sulfate/ml (Na 2 35 SO4; PerkinElmer, Schwerzenbach, Switzerland). Thereafter NP tissue was digested with 0.5 mg/ ml proteinase K at 56˚C overnight. Conditioned medium and digested tissue samples were analyzed after PD-10 desalting column (GE Healthcare, Glattbrugg, Switzerland) and radioactive counts were measured by Wallac 1414 Liquid Scintillation Counter (PerkinElmer, Schwerzenbach, Switzerland). The counts per minute (cpm) were normalized to the DNA content of the respective samples.
Safranin O/Fast Green Staining After 14 days of culture with repetitive loading and free swelling recovery, whole discs with implanted biomaterials were fixed in formalin and transferred into PBS with 5% sucrose at 4˚C overnight before cryosectioning. After removing one endplate with a scalpel blade, transverse cryosections were cut at a thickness of 12 mm through the central area of the IVD. Sections were stained with 0.1% Safranin-O and 0.02% Fast Green to reveal proteoglycan and collagen deposition, respectively, and counterstained with Weigert's Haematoxylin to reveal cell distribution.
Fourier Transform Infrared (FTIR) Microscopic Imaging
After 14 days of culture with repetitive loading and free swelling recovery, a set of discs were fixed in formalin, decalcified and embedded in paraffin. Sagittal sections at a thickness of 4 mm were cut and mounted on custom made reflective 316 stainless steel slides for infrared analysis. FTIR microscopic images were collected using an Agilent 680-IR FTIR spectrometer (Agilent Technologies UK Ltd, Wokingham, Berkshire, UK) coupled to a FTIR imaging microscope fitted with a liquid nitrogen cooled 64 Â 64 mercury-cadmium-telluride focal plane array detector (FPA) and an automated sampling stage. For each sample, an area of 71 Â 192 pixels (approximately 6.3 Â 16.8 mm) was mapped in transflectance mode. Spectra were attained with a spectral resolution of 4 cm À1 over a wavenumber range of 950-1,900 cm À1 . Data was pre-processed by performing a , Malvern Instruments Limited, Worcestershire, UK) on the spectra to reduce baseline effects and assist the resolution of weaker absorption peaks. 30 Pixels within the tissue section where spectra indicated only the presence of paraffin or substrate were identified and masked using spectral statistics (ISys50 1 , histogram). Regions of interest (ROI; 10 Â 192 pixels) across the middle of each sagittal section were cut and compiled to one data matrix. The data set was analyzed using a multivariate curve resolution-alternating least squares algorithm (MCR-ALS) described by Andrew Immunohistochemical Staining of Aggrecan, Collagen Type II, and Collagen Type I Aggrecan, collagen type II and collagen type I were identified using immunohistochemical analysis. After 14 days of culture with repetitive loading and free swelling recovery, discs were fixed in formalin, decalcified, paraffin embedded and cut sagittally at 5 mm thickness. The sections were deparaffinised, rehydrated through an ethanol gradient, and boiled in citrate, pH 6.0, as a pretreatment to retrieve the antigens.
Sections for aggrecan underwent a reduction and alkylation step, were blocked for endogenous peroxidase and treated with chondroitinase ACII (0.25 U/ml). Sections for collagen type II and collagen type I were blocked for endogenous peroxidase and treated with hyaluronidase (1.5 U/ml). All sections were then blocked with horse serum and incubated with the appropriate primary antibody for 30 min at room temperature: anti-aggrecan (12/21/1-C-6, monoclonal mouse, 1:10 or 5 mg Ig/ml; Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA), anticollagen type II (CIICI, monoclonal mouse, 1:12 or 5.4 mg Ig/ ml; Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA) or anti-collagen type I antibody (COL-1, monoclonal mouse, 1:4000; Sigma). This was followed by incubation with a biotinylated horse anti-mouse secondary antibody and an avidin-biotin-peroxidase system (Vectastain Elite ABC kit, Vector Laboratories); the peroxidase was finally visualized with a DAB system (ImmPACT DAB, Vector Laboratories). Negative control sections were incubated without the primary antibody.
Statistical Analysis SPSS 21.0 software was used for statistical analysis. One sample Kolmogorov-Smirnov test was used to define whether the data were normally distributed (normal distribution at p > 0.1). For data that were normally distributed, one-way ANOVA with Tukey post hoc test was used to determine differences among three or more groups, unpaired T-test was used to determine differences between two groups. For data that were not normally distributed, Kruskal-Wallis test was used to determine differences among three or more groups, Mann-Whitney U-test was used to determine differences between two groups. A p-value <0.05 was considered statistically significant; p-value <0.1 was considered to indicate a trend.
RESULTS
Effect of BMP-2/7 Heterodimer on NP Cells in Vitro ACAN, COL1A2 and COL2A1 gene expression levels of NP cells encapsulated in FBG-HA hydrogels after 7 or 14 days of culture were normalized to the expression levels of cells at day 0 (after isolation from NP tissue, Fig. 1A) . On day 7, there was a trend of higher ACAN expression in hydrogels containing 5,000 ng/ml of BMP-2/7 compared with hydrogels without (p ¼ 0.073) BMP-2/7. Compared with 1,000 ng/ml of BMP-2/7, the dose of 5,000 ng/ml significantly upregulated of ACAN, COL1A2, and COL2A1 gene expression of NP cells (p < 0.05). On day 14, markedly higher COL2A1 expression was observed in hydrogels containing 5,000 ng/ml of BMP-2/7 compared with hydrogels without and with 1,000 ng/ml of BMP-2/7 (p < 0.05). ACAN gene expression also showed a significantly higher level in the 5,000 ng/ml group compared with the 1,000 ng/ml group (p < 0.05) (Fig. 1A) .
The DNA content was enhanced by BMP-2/7 in the first 7 days of culture, indicating higher cell proliferation. However, after 14 days, the DNA amount was not affected by BMP-2/7 incorporation into the hydrogel (Fig. 1B) . The GAG/DNA values were significantly increased in hydrogels with 1,000 (p < 0.01) or 5,000 ng/m (p < 0.001) BMP-2/7 after 7 days (Fig. 1C) . The collagen synthesis of the NP cells was not significantly influenced by BMP-2/7 incorporation (Fig. 1 D) .
Effect of BMP-2/7 Heterodimers on IVDs With NP Replacement Under Dynamic Loading Ex Vivo
Disc Height Change A diurnal disc height change pattern was observed during the entire period of 14 days of repetitive load ( Fig. 2A) . Compared with the initial disc height after dissection, a disc height loss of À3.6% to À0.3% was observed after 3 h of dynamic loading. After free swelling, the discs height recovered, whereby an increase of 4.7-11.7% was observed. The disc height after recovery did not significantly change over the 15 days of culture.
Gene Expression
Gene expression levels after 14 days of culture were compared to the expression levels of disc tissue from respective tails before starting organ culture on day 0 (Fig. 2B and C) . Compared with day 0, the gene expression of ACAN in NP of discs with hydrogel, but without BMP-2/7, did not change. When FBG-HA hydrogel containing BMP-2/7 was implanted, the gene expression of ACAN in NP increased 4.5-fold (Fig. 2B) .
Compared with day 0, gene expression of ACAN, COL1A2, MMP13, ALPL and Versican increased, while gene expression of COL2A1 decreased in the AF of discs without BMP-2/7. The implantation of FBG-HA hydrogel containing BMP-2/7 did not show significant effects on the expression of these genes in the AF (Fig. 2C) .
Biochemical Analysis GAG content, collagen content and PG synthesis rate per cell of NP and AF tissue in partially nucleotomized discs treated with hydrogel with/without BMP-2/7 incorporation are shown in Table 2 . In the remaining NP in contact with the hydrogel-growth factor implants, the GAG/DNA ratio increased by 46% when BMP-2/7 was incorporated (p ¼ 0.113). The Collagen/ DNA ratio and PG synthesis rate/DNA ratio were not affected by addition of BMP-2/7 to the hydrogel. In the AF, neither GAG/DNA ratio nor Collagen/DNA ratio was affected by BMP-2/7 incorporation.
Histological Analysis of Whole Discs
Images of Safranin O/Fast Green stained transverse sections of discs cultured for 14 days are shown in Figure 3 . In line with a previous study on the PU scaffold for NP replacement, 27 the swollen PU scaffold filled the nucleotomized region completely (Fig. 3A  and C) . The envelope of the PU scaffold was observed as a ring in direct contact with the remaining NP. The core of the PU scaffold essentially consists of water and therefore appears as an empty non-stained region in the center of the disc section. Part of the FBG-HA hydrogel with/without BMP-2/7 diffused into the envelope of the PU scaffold, as indicated by the intense red Safranin-O staining due to the HA component in the hydrogel (Fig. 3B and D) . The remaining native NP continued to present intense proteoglycan staining with Safranin O after 14 days of culture with dynamic load.
FTIR Imaging Analysis of Disc Tissue
A tissue distribution image (sagittal direction) of a paraffin embedded partially nucleotomized disc treated with hydrogel without BMP-2/7 (0 ng/ml BMP-2/7) and cultured for 14 days under dynamic load is shown in Figure 4A . Tissue distribution maps of ROI of discs treated with hydrogel with 0 ng/ml BMP-2/7 (top) or 5,000 ng/ml BMP-2/7 (bottom) cultured for 14 days 
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under dynamic load are shown in Figure 4B . Both ROI images show a cavity in the center of the disc where the implant was situated, surrounded by native disc tissue. Estimated component / tissue distribution line profiles of proteoglycan, collagen type II and collagen type I across the IVD sections display distinctive trends, with proteoglycan and collagen II profiles showing an overall increase and collagen I profiles revealing a decrease from the outer AF towards the central NP region (Fig. 4C) . A comparison of the line profiles between samples treated with hydrogel with and without BMP-2/7 indicates very similar trends for proteoglycan, collagen II, and collagen I. However, localized differences in component per tissue ratios are observed. While the disc treated with 0 ng/ml BMP-2/7 shows a lower proteoglycan per tissue ratio than the disc treated with 5,000 ng/ml BMP-2/7 in most areas across the disc, localized higher proteoglycan per tissue ratios are observed in two regions at around 26-30% and 34-38% IVD width. Distribution line profiles of collagen II for discs treated with 0 and 5,000 ng/ml BMP-2/7 show similar trends in comparison to the proteoglycan distributions. The collagen I line profile of the disc treated with hydrogel and 0 ng/ml BMP-2/7 shows higher component tissue ratios in the regions around 12-21% and 23-27% IVD width, but localized lower component to tissue ratios (sharp negative features) at around 27-32% and 34-36% width in comparison to the disc treated with hydrogel and 5,000 ng/ml BMP-2/7. In the region of 70-98% width the collagen I line profile shows comparable component per tissue ratios for the disc treated with 0 and 5,000 ng/ml BMP-2/7.
Immunohistochemical Staining of Whole Discs
Images of aggrecan, collagen type II and collagen type I stained sagittal sections of discs cultured for 14 days are shown in Figure 5 . Aggrecan (Fig. 5A ) and collagen type II (Fig. 5E ) images showed an overall increased staining intensity, while collagen type I (Fig. 5I ) revealed a decreased staining intensity from the outer AF towards the central NP region, which confirmed the findings from Safranin O/Fast Green staining and FTIR analysis. Neither aggrecan (Fig. 5C and D) nor collagen type I staining intensity ( Fig. 5K and L) revealed any noticeable difference between the partially nucleotomized disc with or without BMP-2/7 supplementation. In the native NP tissue close to the nucleotomy cavity, collagen type II appeared to express increased staining intensity in the discs treated with 5,000 ng/ml BMP-2/7 ( Fig. 5G and H) .
DISCUSSION
Fibrinogen-hyaluronan conjugate hydrogel has previously been evaluated as a favorable biomaterial for nucleus pulposus regeneration. 24 Here we first investigated the dose effect of BMP-2/7 covalently incorporated within the FBG-HA hydrogel by encapsulating NP cells in the hydrogel. The proliferation rate of the NP cells was boosted by BMP-2/7 in the first 7 days of culture, but not affected by day 14. Incorporation of BMP-2/7 at the concentrations of 1,000 and 5,000 ng/ ml both stimulated the GAG synthesis. In addition, NP cells treated with 5,000 ng/ml of BMP-2/7 showed significantly higher ACAN and COL2A1 gene expression levels after 7 and 14 days, which indicates a stimulatory effect on the production of NP like extra- 
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LI ET AL. cellular matrix after further culture. These results are in line with previous in vitro cell culture studies performed with BMP-2 7-9 and BMP-7 [11] [12] [13] and further corroborate that BMP-2/7 can stimulate the extracellular matrix production of NP cells in 3D culture.
Based on the results of the in vitro study, the dose of 5,000 ng/ml BMP-2/7 was selected for the IVD organ culture experiments. Freshly dissected IVD on day 0 was selected as the positive control, as the cell phenotype and extracellular matrix composition of the day 0 control represents the optimal condition compared to intact IVDs cultured for 14 days. To focus on the effect of BMP-2/7 growth factor treatment, negative controls of nucleotomized IVDs with hydrogel carrier without BMP-2/7 were used. After 14 days of culture with repetitive dynamic load, BMP-2/7 delivered into the partially nucleotomized disc up-regulated the ACAN gene expression in the remaining NP tissue. The FTIR spectrum also showed higher proteoglycan intensity over most areas of the sagittal IVD sections in the BMP-2/7 treated discs. In biochemical analysis, although not significant, the GAG/DNA ratio was upregulated 1.5-fold in the NP and 2.3-fold in the AF with the delivery of BMP-2/7. These results indicate that the covalently incorporated BMP-2/7 has the potential to stimulate the gene expression and synthesis of proteoglycan components in the NP of partially nucleotomized discs.
A study by Huang et al. reported negative effects after intradiscal injection of 100 mg BMP-2 into rabbit lumbar discs. 34 Fibroblastic tissue, osteophyte formation, and hypertrophy of cartilaginous endplate were observed at 12 weeks after surgery. In the current IVD organ culture study, the COL1 and ALPL gene expression levels in the native tissue were not dysregulated by BMP-2/7 treatment. The Safranin O/Fast Green staining also revealed intense proteoglycan staining in the remaining NP after partial nucleotomy and BMP-2/7 treatment. These results demonstrate that the BMP-2/7 applied at the current concentration (0.25-0.4 mg/disc) and in the formulation of covalent binding to FBG-HA had neither adverse fibroblastic nor osteogenic effects. This is consistent with a study by Kim et al. 9 where the exposure of human disc cells, cultured in 3D beads, to BMP-2 did not result in an osteogenic response, whereas proteoglycan synthesis Total glycosaminoglycan (GAG) content, total collagen content and proteoglycan (PG) synthesis rate were measured and normalized to the DNA content of the respective samples. GAG/DNA ratio in mg/mg; Collagen/DNA ratio in mg/mg, PG/DNA in counts per minute (CPM)/mg; PG/DNA was measured for NP tissue only. Mean AE SEM, n ¼ 6. was increased in NP cells. The dose, the exposed cell type, and the delivery method of growth factors play an important role in directing the fate of the cell phenotype. Importantly, leakage of growth factor out of the disc space substantially increases the risk for unwanted effects on other cell types. The covalent binding of BMP-2/7 to the FBG-HA hydrogel provides a depot of growth factor, avoiding the need for repetitive application, and at the same time minimizes the potential for leakage. ). The black square indicates a region of interest (ROI) which was used to investigate the matrix distribution of native disc tissue surrounding the implant cavity. (B) FTIR tissue distribution maps of ROIs of a disc implanted with PU scaffolds treated with hydrogel without BMP-2/7 (top) and treated with 5,000 ng/ml BMP-2/7 (bottom) cultured for 14 days under dynamic load (scale bar: white to black indicative of a low to high tissue content). (C) Estimated component per tissue distribution line profiles across the ROI normalised to 100 % IVD width for proteoglycan, collagen type II and collagen type I.
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Although the biochemical analysis revealed higher matrix synthesis and content after incorporation of growth factor compared to pure hydrogel delivery, these results did not reach statistical significance. An explanation might be the relatively short observation time in combination with a delivery system that requires hydrogel degradation for growth factor release. 23 Longer culture periods may be needed to detect a significant impact of sustained release BMP-2/7 delivery on the tissue matrix level. Furthermore, combinations of different growth factors might show superior efficacy. Synergistic effects of BMP and other growth factors on disc cells have been documented. [35] [36] [37] [38] BMP-7 and insulin like growth factor one potentiated anabolic stimulation through complementary mechanisms on matrix formation of bovine NP cells compared with treatment with either growth factor alone. 37 Porcine AF cell treatment with BMP-2 and transforming growth factor beta 1 caused a greater decrease in MMP-1 and increase in aggrecan than either growth factor alone. 35 In another study, bovine NP cells were cultured with BMP-7 and lactoferricin B. 36 It was found that lactoferricin B maximized the regenerative activity of BMP-7 by inhibiting noggin. Human degenerative NP cell cotransfection with BMP-7 and Sox9 also showed a synergistic effect on type II collagen transcription. 38 However, all these studies were performed using disc cells cultured in vitro, thereby lacking the tissue and organ specific microenvironment. Further studies will be required to elucidate the synergistic effect of BMP and other growth factors for IVD regeneration. The use of the described IVD whole organ nucleotomy model could provide information at higher relevance level for clinical translation.
CONCLUSION
Covalently incorporated BMP-2/7 can stimulate ACAN and COL2A1 expression and GAG synthesis of bovine NP cells cultured in FBG-HA hydrogel. In an IVD organ model, BMP-2/7 delivered into the nucleotomized region has the potential to promote the phenotype and synthesis of proteoglycan in the remaining NP, without causing fibroblastic or osteogenic induction. Intradiscal delivery of BMP-2/7 may be a promising therapeutic approach for NP regeneration. This partial nucleotomy organ culture model may be utilized for screening of other biomaterials or bioactive factors to treat early disc degeneration.
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